| Jessica Parfitt, | |
|
131 Talbooth St, Aberdeen, NC 28315-2835 | |
| (910) 229-9731 | |
| Not Available |
| Full Name | Jessica Parfitt |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 7 Years |
| Location | 131 Talbooth St, Aberdeen, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972032050 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | LCAS-23837 (North Carolina) | Secondary |
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
| Entity Name | Lotus Counseling Center, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891393831 PECOS PAC ID: 9032522552 Enrollment ID: O20201230001148 |
News Archive
XTIO2 INC. (XTI) presented the 83rd Academy® Award-nominees with the XTI ANTI-GERM / ANTI-VOC / ANTI-ALLERGY SYSTEM, consisting of XTI 360™ Nanocoating and XTI™ Nano-Facemask. It is the world's most effective preventive measure and the best defense against germs transmitted via air and contact surfaces.
Patients with end-stage renal disease (ESRD) who participated in an education program to limit their intake of phosphorus-containing food additives lowered their blood levels of the chemical, according to a study in the February 11 issue of JAMA, the Journal of the American Medical Association.
A new study released Tuesday in the Annals of Internal Medicine suggests that sleeping may help one to lose fat. The study compared two groups of people who were trying to lose weight. One group was assigned to sleep 5.5 hours each night for two weeks, while the other was able to sleep 8.5 hours. The scientists found that the sleep deprived people had higher levels of ghrelin. It may be this hormone that drives appetite that leads to excess eating, believe researchers.
The Johns Hopkins University School of Medicine has announced receipt of a five-year, $27 million gift earmarked to fast-track the development of therapies to treat tumors associated with neurofibromatosis type 1 (NF1), a common and often debilitating neurogenetic disorder that causes tumors called plexiform neurofibromas to grow on nerves anywhere in the body.
A new cancer research program at Loyola University Chicago Stritch School of Medicine will develop therapies designed to turn patients' own immune systems into potent weapons against cancer.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Parfitt, 168 Foxcroft Rd, Carthage, NC 28327-8918 Ph: (910) 229-9731 | Jessica Parfitt, 131 Talbooth St, Aberdeen, NC 28315-2835 Ph: (910) 229-9731 |
News Archive
XTIO2 INC. (XTI) presented the 83rd Academy® Award-nominees with the XTI ANTI-GERM / ANTI-VOC / ANTI-ALLERGY SYSTEM, consisting of XTI 360™ Nanocoating and XTI™ Nano-Facemask. It is the world's most effective preventive measure and the best defense against germs transmitted via air and contact surfaces.
Patients with end-stage renal disease (ESRD) who participated in an education program to limit their intake of phosphorus-containing food additives lowered their blood levels of the chemical, according to a study in the February 11 issue of JAMA, the Journal of the American Medical Association.
A new study released Tuesday in the Annals of Internal Medicine suggests that sleeping may help one to lose fat. The study compared two groups of people who were trying to lose weight. One group was assigned to sleep 5.5 hours each night for two weeks, while the other was able to sleep 8.5 hours. The scientists found that the sleep deprived people had higher levels of ghrelin. It may be this hormone that drives appetite that leads to excess eating, believe researchers.
The Johns Hopkins University School of Medicine has announced receipt of a five-year, $27 million gift earmarked to fast-track the development of therapies to treat tumors associated with neurofibromatosis type 1 (NF1), a common and often debilitating neurogenetic disorder that causes tumors called plexiform neurofibromas to grow on nerves anywhere in the body.
A new cancer research program at Loyola University Chicago Stritch School of Medicine will develop therapies designed to turn patients' own immune systems into potent weapons against cancer.
› Verified 2 days ago